EUVIMEDEUVIMED entdecken
Crossref

Dysfunction of neurotransmitter metabolism is associated with the severity of depression in first-diagnosed, drug-naïve depressed patients

Tingyu Zhao, Ting Liu, Lu Wang, Kaiqiang Xie, Hui Tang, Mimi Tang

Journal of Affective Disorders · 2024-03 · 349 · 332-341

DOI: 10.1016/j.jad.2024.01.023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2024-03. Verfasst von Tingyu Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China; National Clinical Research Center for Ger…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Phenylacetates. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Natural Science Foundation of Changzhou Municipality, National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Biochemical changes of neurotransmitters underlying major depressive disorder (MDD) are unknown. This study preliminarily explored the association between neurotransmitters with MDD and the possibility of objective laboratory prediction of neurotransmitter involvement in MDD. METHODS: A total of 87 first-diagnosed, drug-naïve patients with depression and 50 healthy controls (HCs) were included in the cross-sectional study. The levels and turnovers of neurotransmitters (glutamine (GLN), glutamic acid (GLU), γ-2Aminobutiric acid (GABA), kainate (KA), vanillylmandelic acid (VMA), 3-methoxy 4-hydroxyphenyl ethylene glycol (MHPG), noradrenaline (NE), homovanillic acid (HVA), dihydroxy-phenyl acetic acid (DOPAC), dopamine (DA), tryptophane (TRP), kynurenine (KYN), serotonin (5-HT), 5-hydroxyindoleacetic acid (5-HIAA)) were determined and the confounding factors were adjusted. Then a correlation and a predictive analysis towards neurotransmitters for MDD were performed. RESULTS: After adjusting confounding factors, GLU (OR = 1.159), (GLU+ GABA)/GLN (OR = 1.217), DOPAC (OR = 1.106), DOPAC/DA (OR = 1.089) and (DOPAC+ HVA)/DA (OR = 1.026) enacted as risk factors of MDD, while KYN (OR = 0.992) was a protective factor. GABAergic and TRPergic pathways were associated with severity of depressive and anxiety symptoms in patients with depression. The predictive model for MDD (AUC = 0.775, 95%CI 0.683-0.860) consisted of KYN (OR = 0.990) and (GLU + GABA)/GLN (OR = 4.101). CONCLUSIONS: First-diagnosed, drug-naïve depression patients showed abnormal neurotransmitter composition. GLU, (GLU + GABA)/GLN, DOPAC, DOPAC/DA and (DOPAC + HVA)/DA were risk factors of MDD, while KYN was a protective factor. GABAergic and TRPergic pathways were correlated with MDD clinical characteristics. KYN and (GLU + GABA)/GLN may have a predictive value for MDD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderPhenylacetatesHumansDepression3,4-Dihydroxyphenylacetic AcidCross-Sectional StudiesDopamineNeurotransmitter AgentsHomovanillic AcidKynurenineGlutamic AcidGlutamineSerotoningamma-Aminobutyric Acid

Stichwörter der Autor:innen

Association and predictionDepressionFirst-diagnosed and drug-naïve patientsMetabolic pathwayNeurotransmitters

Substanzen

3,4-Dihydroxyphenylacetic AcidDopamineNeurotransmitter AgentsHomovanillic AcidKynurenineGlutamic AcidGlutamineSerotoninphenylacetic acidgamma-Aminobutyric Acid

Autor:innen und Institutionen

  • Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha…
  • The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders and Beijing Institute for Brain Disorders Center of Schizophrenia, Beijing Anding Hospital, Capital Medical Unive…
  • National Clinical Research Center for Mental Disorders, China National Technology Institute on Mental Disorders and Department of Psychiatry, The Second Xiangya Hospital of Central South University, Changsha 410011, Hun…

Förderung

  • Natural Science Foundation of Changzhou Municipality
  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province
  • Xiangya Hospital, Central South University
  • China Postdoctoral Science Foundation

Zitieren

APA

Zhao, T., Liu, T., Wang, L., Xie, K., Tang, H., & Tang, M. (2024). Dysfunction of neurotransmitter metabolism is associated with the severity of depression in first-diagnosed, drug-naïve depressed patients. Journal of Affective Disorders, 349, 332-341. https://doi.org/10.1016/j.jad.2024.01.023

Vancouver

Zhao T, Liu T, Wang L, Xie K, Tang H, Tang M. Dysfunction of neurotransmitter metabolism is associated with the severity of depression in first-diagnosed, drug-naïve depressed patients. Journal of Affective Disorders. 2024;349:332-341. doi:10.1016/j.jad.2024.01.023

BibTeX
@article{Zhao2024,
  author = {Zhao, Tingyu and Liu, Ting and Wang, Lu and Xie, Kaiqiang and Tang, Hui and Tang, Mimi},
  title = {Dysfunction of neurotransmitter metabolism is associated with the severity of depression in first-diagnosed, drug-naïve depressed patients},
  journal = {Journal of Affective Disorders},
  year = {2024},
  volume = {349},
  pages = {332--341},
  doi = {10.1016/j.jad.2024.01.023}
}
Kostenlos starten →